1. A New Approach to Treat Childhood Leukemia: Novartis' CAR-T Therapy. Issue 4 (2017) Authors: Tessema, Frazer A.; Darrow, Jonathan J. Editors: Goldberg, Daniel S. Journal: Journal of law, medicine & ethics Issue: Volume 45:Issue 4(2017) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A New Approach to Treat Childhood Leukemia: Novartis' CAR-T Therapy. Issue 4 (December 2017) Authors: Tessema, Frazer A.; Darrow, Jonathan J. Other Names: Goldberg Daniel S. guest-editor. Journal: Journal of law, medicine & ethics Issue: Volume 45:Issue 4(2017) Page Start: 692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Approximating Future Generic Entry for New Drugs. Issue 1 (2019) Authors: Beall, Reed F.; Darrow, Jonathan J.; Kesselheim, Aaron S. Editors: Cook-Deegan, Robert; Majumder, Mary A.; McGuire, Amy L. Journal: Journal of law, medicine & ethics Issue: Volume 47:Issue 1(2019) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Approximating Future Generic Entry for New Drugs. Issue 1 (March 2019) Authors: Beall, Reed F.; Darrow, Jonathan J.; Kesselheim, Aaron S. Other Names: Cook-Deegan Robert guest-editor.; Majumder Mary A. guest-editor.; McGuire Amy L. guest-editor. Journal: Journal of law, medicine & ethics Issue: Volume 47:Issue 1(2019) Page Start: 177 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development Speed. Issue 4 (1st July 2021) Authors: Pregelj, Lisette; Hine, Damian C.; Kesselheim, Aaron S.; Darrow, Jonathan J. Journal: Clinical pharmacology & therapeutics Issue: Volume 110:Issue 4(2021) Page Start: 1018 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Comparing Onset of Biosimilar Versus Generic Competition in the United States. Issue 6 (17th August 2020) Authors: Beall, Reed F.; Ronksley, Paul E.; Wick, James; Darrow, Jonathan J.; Sarpatwari, Ameet; Kesselheim, Aaron S. Journal: Clinical pharmacology & therapeutics Issue: Volume 108:Issue 6(2020) Page Start: 1308 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Evidence Supporting the Value of Surgical Procedures: Can We Do Better?. Issue 8 (August 2021) Authors: Darrow, Jonathan J.; Robertson, Christopher T.; Kasoff, Willard S. Journal: American surgeon Issue: Volume 87:Issue 8(2021) Page Start: 1352 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Institutional Corruption of Pharmaceuticals and the Myth of Safe and Effective Drugs. Issue 3 (1st October 2013) Authors: Light, Donald W.; Lexchin, Joel; Darrow, Jonathan J. Journal: Journal of law, medicine & ethics Issue: Volume 41:Issue 3(2013) Page Start: 590 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Luxturna: FDA documents reveal the value of a costly gene therapy. Issue 4 (April 2019) Authors: Darrow, Jonathan J. Journal: Drug discovery today Issue: Volume 24:Issue 4(2019) Page Start: 949 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Origins and Ownership of Remdesivir: Implications for Pricing. Issue 3 (2020) Authors: Lee, ChangWon C.; Darrow, Jonathan J.; Avorn, Jerry; Kesselheim, Aaron S. Editors: Clark, Brietta R.; Fuse Brown, Erin C.; Wiley, Lindsay F. Journal: Journal of law, medicine & ethics Issue: Volume 48:Issue 3(2020) Page Start: 613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗